Cargando…

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women

Detalles Bibliográficos
Autores principales: Ngemu, Erastus K, Khayeka–Wandabwa, Christopher, Kweka, Eliningaya J, Choge, Joseph K, Anino, Edward, Oyoo-Okoth, Elijah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534025/
https://www.ncbi.nlm.nih.gov/pubmed/25471546
http://dx.doi.org/10.1186/1756-0500-7-868
_version_ 1782385397865644032
author Ngemu, Erastus K
Khayeka–Wandabwa, Christopher
Kweka, Eliningaya J
Choge, Joseph K
Anino, Edward
Oyoo-Okoth, Elijah
author_facet Ngemu, Erastus K
Khayeka–Wandabwa, Christopher
Kweka, Eliningaya J
Choge, Joseph K
Anino, Edward
Oyoo-Okoth, Elijah
author_sort Ngemu, Erastus K
collection PubMed
description
format Online
Article
Text
id pubmed-4534025
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45340252015-08-13 Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women Ngemu, Erastus K Khayeka–Wandabwa, Christopher Kweka, Eliningaya J Choge, Joseph K Anino, Edward Oyoo-Okoth, Elijah BMC Res Notes Retraction Note BioMed Central 2014-11-25 /pmc/articles/PMC4534025/ /pubmed/25471546 http://dx.doi.org/10.1186/1756-0500-7-868 Text en © Ngemu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Retraction Note
Ngemu, Erastus K
Khayeka–Wandabwa, Christopher
Kweka, Eliningaya J
Choge, Joseph K
Anino, Edward
Oyoo-Okoth, Elijah
Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title_full Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title_fullStr Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title_full_unstemmed Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title_short Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
title_sort retraction note: effectiveness of option b highly active antiretroviral therapy (haart) prevention of mother-to-child transmission (pmtct) in pregnant hiv women
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534025/
https://www.ncbi.nlm.nih.gov/pubmed/25471546
http://dx.doi.org/10.1186/1756-0500-7-868
work_keys_str_mv AT ngemuerastusk retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen
AT khayekawandabwachristopher retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen
AT kwekaeliningayaj retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen
AT chogejosephk retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen
AT aninoedward retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen
AT oyoookothelijah retractionnoteeffectivenessofoptionbhighlyactiveantiretroviraltherapyhaartpreventionofmothertochildtransmissionpmtctinpregnanthivwomen